毛细支气管炎患儿无创正压通气与院内心脏骤停
该研究为北美单中心四级PICU的回顾性队列,纳入虚拟儿科系统数据库中诊断为毛细支气管炎的4698例ICU住院患儿,主要暴露为NIPPV,主要结局为院内心脏骤停(IHCA)。IHCA发生率为1.2%(57/4698),IHCA发生时最常见呼吸支持为有创机械通气(65%,37/57),12%(7/57)正在接受NIPPV。在仅接受NIPPV或IMV的患者中,多因素分析显示NIPPV暴露与较低的IHCA风险相关(aOR 0.07;95%CI 0.03-0.18),相比IMV。全部患者二次分析中,相比IMV,NIPPV与较低IHCA风险相关(aOR 0.35;95%CI 0.14-0.87),而最小呼吸支持(无/鼻导管/加温湿化高流量鼻导管)与IMV相比无差异(aOR 0.56;95%CI 0.23-1.36)。作者认为毛细支气管炎患儿心脏骤停不常见,NIPPV使用与较低的IHCA风险相关。
要点
- 毛细支气管炎ICU住院患儿IHCA发生率为1.2%(57/4698),IHCA发生时65%(37/57)接受有创机械通气,12%(7/57)接受NIPPV。
- 仅接受NIPPV或IMV的患者中,NIPPV暴露与IHCA风险降低相关(aOR 0.07;95%CI 0.03-0.18),相比IMV。
- 全部患者二次分析中,相比IMV,NIPPV与较低IHCA风险相关(aOR 0.35;95%CI 0.14-0.87),最小呼吸支持与IMV相比无差异(aOR 0.56;95%CI 0.23-1.36)。
- IHCA患儿较无IHCA患儿PRISM-III评分更高(3[0-8] vs 0[0-2];p<0.001)、复杂慢性病更多(94.7% vs 46.2%;p<0.001)、死亡率更高(21.1% vs 1.0%;p<0.001)。
- IHCA后93%(53/57)实现ROSC,79%(45/57)存活至出院;7例无慢性病且IHCA时有活动性毛细支气管炎症状的患儿全部实现ROSC,86%(6/7)存活至出院。
适用人群与场景
- 北美单中心四级PICU中,虚拟儿科系统数据库内国际疾病分类主要或次要诊断为毛细支气管炎的儿童ICU住院患儿。
研究设计与关键结果
- 研究类型:单中心回顾性队列研究;样本量:4698例符合条件的毛细支气管炎ICU住院患儿;研究场所:北美单中心四级PICU。
- 主要暴露为NIPPV,主要结局为IHCA;IHCA发生率为1.2%(57/4698)。
- IHCA发生时呼吸支持:有创机械通气最常见(65%,37/57),NIPPV占12%(7/57)。
- IHCA患儿 vs 无IHCA患儿:PRISM-III评分3[0-8] vs 0[0-2](p<0.001);复杂慢性病94.7% vs 46.2%(p<0.001);死亡率21.1% vs 1.0%(p<0.001)。
- IHCA后93%(53/57)实现ROSC,79%(45/57)存活至出院。
- 7例无慢性病且IHCA时有活动性毛细支气管炎症状的患儿全部实现ROSC,86%(6/7)存活至出院。
- 仅接受NIPPV或IMV的患者中,多因素分析显示NIPPV暴露与IHCA风险降低相关(aOR 0.07;95%CI 0.03-0.18),相比IMV。
- 全部患者二次分析中,相比IMV,NIPPV与较低IHCA风险相关(aOR 0.35;95%CI 0.14-0.87);最小呼吸支持(无/鼻导管/加温湿化高流量鼻导管)与IMV相比无差异(aOR 0.56;95%CI 0.23-1.36)。
证据类型、等级与局限
- 证据类型:单中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为毛细支气管炎患儿心脏骤停不常见,NIPPV使用与较低的IHCA风险相关。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: A recent study showed an association between high hospital-level noninvasive positive pressure ventilation (NIPPV) use and in-hospital cardiac arrest (IHCA) in children with bronchiolitis.
OBJECTIVES: We aimed to determine if patient-level exposure to NIPPV in children with bronchiolitis was associated with IHCA.
DESIGN, SETTING AND PARTICIPANTS: Retrospective cohort study at a single-center quaternary PICU in North America including children with International Classification of Diseases primary or secondary diagnoses of bronchiolitis in the Virtual Pediatric Systems database.
MAIN OUTCOMES AND MEASURES: The primary exposure was NIPPV and the primary outcome was IHCA.
MEASUREMENTS AND MAIN RESULTS: Of 4698 eligible ICU admissions with bronchiolitis diagnoses, IHCA occurred in 1.2% (57/4698). At IHCA onset, invasive mechanical ventilation (IMV) was the most frequent level of respiratory support (65%, 37/57), with 12% (7/57) receiving NIPPV. Patients with IHCA had higher Pediatric Risk of Mortality-III scores (3 [0-8] vs. 0 [0-2]; p < 0.001), more frequently had a complex chronic condition (94.7% vs. 46.2%; p < 0.001), and had higher mortality (21.1% vs. 1.0%; p < 0.001) compared with patients without IHCA. Return of spontaneous circulation (ROSC) was achieved in 93% (53/57) of IHCAs; 79% (45/57) survived to hospital discharge. All seven children without chronic medical conditions and with active bronchiolitis symptoms at the time of IHCA achieved ROSC, and 86% (6/7) survived to discharge. In multivariable analysis restricted to patients receiving NIPPV or IMV, NIPPV exposure was associated with lower odds of IHCA (adjusted odds ratio [aOR], 0.07; 95% CI, 0.03-0.18) compared with IMV. In secondary analysis evaluating categorical respiratory support in all patients, compared with IMV, NIPPV was associated with lower odds of IHCA (aOR, 0.35; 95% CI, 0.14-0.87), whereas no difference was found for minimal respiratory support (none/nasal cannula/humidified high-flow nasal cannula [aOR, 0.56; 95% CI, 0.23-1.36]).
CONCLUSIONS AND RELEVANCE: Cardiac arrest in children with bronchiolitis is uncommon, occurring in 1.2% of bronchiolitis ICU admissions. NIPPV use in children with bronchiolitis was associated with lower odds of IHCA.
参考来源
- Shepard LN, Mehta S, Graham K, et al. Noninvasive Positive Pressure Ventilation Use and In-Hospital Cardiac Arrest in Bronchiolitis. Crit Care Explor. 2024. PMID: 38747691. doi:10.1097/CCE.0000000000001088
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。